IntegriCulture adds ¥100M from Niigata Venture Capital to its Series A extension and links cell culture to sake lees

Industry Trends · Oct 30, 2026

← Innovative Product News

What Happened

Tokyo-based IntegriCulture has received ¥100 million (about $635,000) from Niigata Venture Capital's Regional Revitalisation Niigata Fund II, according to Green Queen's 30 October 2026 report. The company's 28 October press release confirms the financing was completed but does not disclose the amount. Green Queen says the money belongs to a planned ¥700 million Series A extension, of which ¥375 million has been raised so far, following an ¥800 million Series A in 2020. The company says the funds will go to cosmetics ingredient development, a regional implementation network, B2B sales and in-house infrastructure R&D. It also says it is working with Ichimasa Kamaboko and Tsunan Brewing to use sake lees and algae residue as culture inputs.

Why It Matters

A regional revitalisation fund backing cellular agriculture alongside local food and brewing firms shows one route for financing pilot infrastructure outside Tokyo. The announcement, however, describes commercial priorities led by cosmetics, not a cultivated-meat product approval or a new production milestone.

Brewery side streams may lower the entry cost of cell culture, but only batch-level data will show whether they can carry a food-grade process.

FET's Takeaway

In our analysis, for a food engineer founding a small cell-culture startup, the model is instructive: pairing with breweries can offer side-stream inputs and existing hygienic infrastructure, while cosmetics may generate revenue before food approval. But the announcement does not provide sake-lees media composition, batch consistency, cost per litre or contaminant data, so feedstock variability and food-grade qualification remain open scale-up questions.

Verification source: Green Queen ↗